Enliven Therapeutics
ELVN
#4352
Rank
NZ$4.13 B
Marketcap
NZ$69.09
Share price
12.51%
Change (1 day)
85.80%
Change (1 year)

Earnings for Enliven Therapeutics (ELVN)

Earnings in 2024: -NZ$0.19 Billion

According to Enliven Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$0.19 Billion a decrease over its 2023 earnings that were of -NZ$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enliven Therapeutics from 2022 to 2024

Annual earnings

Year Earnings Change
2024-NZ$0.19 Billion25.17%
2023-NZ$0.15 Billion115.33%
2022-NZ$67.05 Million